China biologic products holdings, inc. (CBPO)
Income statement / Yearly
Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
External customers

-

-

-

-

-

-

-

-

118,293

Related party

-

-

-

-

-

-

-

-

705

Sales

370,406

341,169

296,457

243,251

203,356

184,813

153,092

139,695

118,998

External customers

-

-

-

-

-

-

-

-

32,544

Related party

-

-

-

-

-

-

-

-

77

Cost of sales

125,517

124,034

106,482

80,025

65,484

58,835

46,017

36,951

32,621

Gross profit

244,889

217,134

189,975

163,226

137,872

125,977

107,074

102,744

86,376

Operating expenses
Selling expenses

34,843

11,679

9,973

10,707

10,643

14,421

14,595

7,372

3,529

General and administrative expenses

67,683

54,519

41,391

32,129

36,073

34,034

31,519

24,467

20,706

Research and development expenses

6,503

7,021

6,024

4,161

4,223

3,032

3,978

2,336

1,662

Provision for other receivables in respect of an employee housing development project

-

-

-

5,068

0

0

-

-

-

Impairment loss of goodwill

-

-

-

-

-

-

18,160

0

0

Loss on abandonment and write-off of long-lived assets

-

-

-

-

-

-

6,603

0

0

Income from operations

135,858

143,914

132,585

111,158

86,932

74,489

32,217

68,568

60,477

Other income (expenses)
Equity in income/(loss) of an equity method investee

3,509

2,519

-1,311

8,646

2,170

2,665

1,858

1,070

566

Change in fair value of derivative liabilities

-

-

-

-

-

1,769

11,974

-3,233

-28,915

Interest income

7,623

7,815

5,551

6,644

4,433

2,910

1,356

752

-

Interest expense

583

254

1,727

3,697

1,134

1,269

4,670

2,682

3,930

Loss from disposal of a subsidiary

0

-75

0

0

-

-

-

-

-

Other income (expense), net

-

-

-

-

-

570

-453

1,125

638

Total other income, net

10,549

10,004

2,512

11,593

5,468

6,645

10,065

-2,967

-31,640

Income before income tax expense

146,407

153,919

135,098

122,752

92,401

81,135

42,282

65,601

28,837

Income tax expense

64,171

25,125

20,992

26,639

15,540

15,163

10,899

13,608

10,013

Net income

82,235

128,793

114,105

96,112

76,861

65,971

31,383

51,992

18,823

Less: Net income attributable to noncontrolling interest

14,292

24,014

25,062

25,195

22,259

20,749

13,201

20,449

16,615

Net income attributable to China Biologic Products Holdings, Inc.

67,943

104,779

89,042

70,916

54,601

45,222

18,181

31,542

2,208

Earnings per share of ordinary share:
Basic

2.40

3.79

3.40

2.85

2.05

1.73

0.73

1.34

0.10

Diluted

2.38

3.74

3.27

2.71

1.96

1.62

0.37

1.30

0.10

Weighted average shares used in computation:
Basic

27,361

26,848

25,599

24,427

26,410

26,153

25,028

23,586

21,754

Diluted

27,605

27,249

26,567

25,685

27,572

26,839

26,654

24,176

21,949

Net income

82,235

128,793

114,105

96,112

76,861

65,971

31,383

51,992

18,823

Other comprehensive income/(losses):
Foreign currency translation adjustment, net of nil income taxes

36,861

-31,303

-24,368

-1,918

9,126

1,735

6,846

5,177

524

Comprehensive income

119,097

97,490

89,737

94,193

85,987

67,707

38,230

57,169

19,347

Less: Comprehensive income attributable to noncontrolling interest

17,876

19,026

20,698

24,798

23,951

21,163

15,320

21,831

17,071

Comprehensive income attributable to China Biologic Products Holdings, Inc.

101,220

78,463

69,038

69,395

62,035

46,543

22,909

35,338

2,276